77 results on '"Postma, Dirkje"'
Search Results
2. Pathway analysis of a genome-wide gene by air pollution interaction study in asthmatic children
3. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population
4. Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma
5. Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics
6. Nasal gene expression differentiates COPD from controls and overlaps bronchial gene expression
7. CT-Based Local Distribution Metric Improves Characterization of COPD
8. Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease
9. Cohort Analysis of Exacerbation Rates in Adolescent and Adult Patients Initiating Inhaled Corticosteroids for Asthma: Different Dose–Response Profile by Particle Size
10. Missing heritability: is the gap closing? An analysis of 32 complex traits in the Lifelines Cohort Study
11. Airway wall thickness on HRCT scans decreases with age and increases with smoking
12. Genetic evaluation of the effect of GLCCI1 rs37973 on corticosteroid response in chronic obstructive pulmonary disease
13. The emerging landscape of dynamic DNA methylation in early childhood
14. Targeted high-throughput sequencing of candidate genes for chronic obstructive pulmonary disease
15. Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
16. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
17. Advanced glycation endproducts and their receptor in different body compartments in COPD
18. Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist
19. Meta-analysis identifies seven susceptibility loci involved in the atopic march
20. Old dilemma: asthma with irreversible airway obstruction or COPD
21. Asthma
22. Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
23. Development of a tool to recognize small airways dysfunction in asthma (SADT)
24. Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort
25. Increased activation of blood neutrophils after cigarette smoking in young individuals susceptible to COPD
26. Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study
27. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD
28. Genome-wide association analysis identifies six new loci associated with forced vital capacity
29. Early life microbial exposure and fractional exhaled nitric oxide in school-age children: a prospective birth cohort study
30. Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics
31. ITGB5 and AGFG1 variants are associated with severity of airway responsiveness
32. Inflammatory phenotypes underlying uncontrolled childhood asthma despite inhaled corticosteroid treatment: rationale and design of the PACMAN2 study
33. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study
34. Low-dose CT measurements of airway dimensions and emphysema associated with airflow limitation in heavy smokers: a cross sectional study
35. miR-638 regulates gene expression networks associated with emphysematous lung destruction
36. Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study
37. Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD
38. Using COPD multidimensional indices in routine clinical practice: DOSE meets all criteria
39. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK
40. A gene expression signature of emphysematous lung destruction and its reversal by the tripeptide GHK
41. Role of aberrant metalloproteinase activity in the pro-inflammatory phenotype of bronchial epithelium in COPD
42. Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control
43. A new perspective on optimal care for patients with COPD
44. ‘Het tij zal keren voor COPD’
45. Induction of autoantibodies against lung matrix proteins and smoke-induced inflammation in mice
46. Can AMP induce sputum eosinophils, even in subjects with complete asthma remission?
47. A sequence variant on 17q21 is associated with age at onset and severity of asthma
48. Increased levels of (class switched) memory B cells in peripheral blood of current smokers
49. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice
50. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.